Hepatitis Diagnostic Tests Global Market Report 2025
상품코드:1691857
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 간염 진단 검사 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 예측기간의 성장은 세계의 건강안전 보장에 대한 우려, 맞춤형 검사 전략, 건강 관리 지출 증가로 인한 것으로 예상됩니다. 예측 기간의 주요 동향으로는 검사 기술의 진보, 다른 간염 바이러스에 대한 멀티플렉스 검사, 분자진단의 통합, 디지털 헬스 솔루션, 전략적 제휴 및 파트너십 등이 있습니다.
수혈과 헌혈 증가는 간염 진단 검사 시장의 성장을 가속할 것으로 예상됩니다. 간염 진단 검사는 헌혈이나 수혈 전에 혈액을 철저하게 스크리닝하고 환자의 안전을 확보하기 위해 필수적입니다. 2023년 8월, 영국에 기반을 둔 단체 Royal College of Pathologists는 수혈은 입원 환자에게 가장 일반적으로 이루어지는 치료이며, 영국에서는 연간 200만 가까이의 혈액 성분이 발행되어 수혈되어 3억 파운드(3억 9,069만 달러) 이상의 비용이 들고 있다고 보고하고 있습니다. 따라서, 수혈과 헌혈 증가는 간염 진단 검사 시장의 확대를 지지하고 있습니다.
세계의 간염 환자의 급증도, 간염 진단 검사 시장의 성장을 뒷받침하는 중요한 요인입니다. 간의 염증을 특징으로 하는 간염은 중대한 건강 리스크를 가져오고, 다양한 증상이나 합병증을 일으킬 가능성이 있습니다. 예를 들어, B형 간염 재단에 따르면, 2023년에는 연간 추정 150만명이 간염에 걸려, 이러한 질병이 초래하는 지속적인 과제가 부각되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 간염 진단 검사 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계 간염 진단 검사 시장 :성장률 분석
세계 간염 진단 검사 시장 실적 : 규모와 성장, 2019-2024
세계 간염 진단 검사 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계 간염 진단 검사 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 간염 진단 검사 시장 : 검사 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
혈액검사
영상 검사
간 생검
세계의 간염 진단 검사 시장 : 기술별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
효소 면역 측정법(ELISA)
신속 진단 테스트(RDT)
중합효소 연쇄반응(PCR)
등온 핵산 증폭 검사(INAAT)
기타 기술
세계의 간염 진단 검사 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
진단 실험실
혈액은행
기타 최종 사용자
세계의 간염 진단 검사 시장 : 혈액 검사 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
혈청학적 검사
중합효소 연쇄반응(PCR) 검사
효소 면역 측정법(ELISA)
세계의 간염 진단 검사 시장 : 영상 검사 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
초음파
컴퓨터 단층 촬영(CT)
자기 공명 영상(MRI)
세계의 간염 진단 검사 시장 : 간 생검 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
경피 생검
경경정맥 생검
복강경하 생검
제7장 지역별 및 국가별 분석
세계의 간염 진단 검사 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 간염 진단 검사 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
간염 진단 검사 시장 :경쟁 구도
간염 진단 검사 시장 : 기업 프로파일
Thermo Fisher Scientific Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
Abbott Laboratories : 개요, 상품 및 서비스, 전략 및 재무분석
Danaher Corporation : 개요, 상품 및 서비스, 전략 및 재무분석
Siemens Healthineers AG : 개요, 상품 및 서비스, 전략 및 재무분석
Roche Diagnostics : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
Quest Diagnostics Incorporated
Grifols SA
Hologic Inc.
BioMerieux SA
Beckman Coulter Inc.
Bio-Rad Laboratories Inc.
SD Biosensor Co. Ltd.
QIAGEN NV
DiaSorin SpA
Randox Laboratories Ltd.
Luminex Corporation
Fujirebio Diagnostics Inc.
Trivitron Healthcare Private Limited
Trinity Biotech plc
MP Biomedicals LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
간염 진단 검사 시장(2029년) : 새로운 기회를 제공하는 국가
간염 진단 검사 시장(2029년) : 새로운 기회를 제공하는 부문
간염 진단 검사 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Hepatitis diagnostic tests are medical procedures and laboratory analyses designed to identify and diagnose infections caused by hepatitis viruses, including hepatitis A, B, C, D, and E. These tests are essential for detecting the presence of hepatitis viruses or specific antibodies in a patient's blood or other bodily fluids. The primary goal is to confirm the infection, determine its type, assess severity, and monitor its progression.
The main categories of hepatitis diagnostic tests include blood tests, imaging tests, and liver biopsy. Blood tests involve examining blood samples to assess various constituents such as blood cells, proteins, enzymes, hormones, antibodies, and other chemicals. Various technologies are utilized in these tests, including enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests, polymerase chain reaction (PCR), isothermal nucleic acid amplification tests, and others. These diagnostic tools find applications in diverse healthcare settings such as hospitals, diagnostic laboratories, blood banks, and other medical facilities.
The hepatitis diagnostic tests market research report is one of a series of new reports from The Business Research Company that provides hepatitis diagnostic tests market statistics, including hepatitis diagnostic tests industry global market size, regional shares, competitors with a hepatitis diagnostic tests market share, detailed hepatitis diagnostic tests market segments, market trends, and opportunities, and any further data you may need to thrive in the hepatitis diagnostic test industry. This hepatitis diagnostic tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hepatitis diagnostic tests market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $4.95 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to globalization of healthcare, government initiatives, high disease burden, increased blood safety measures, public health campaigns.
The hepatitis diagnostic tests market size is expected to see strong growth in the next few years. It will grow to $6.24 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to global health security concerns, population growth and urbanization, tailored testing strategies, emphasis on elimination programs, increasing healthcare spending. Major trends in the forecast period include advancements in testing technologies, multiplex testing for different hepatitis viruses, integration of molecular diagnostics, digital health solutions, strategic collaborations and partnerships.
The increasing number of blood transfusions and donations is expected to drive growth in the hepatitis diagnostic test market. Blood transfusions and donations are connected processes in which individuals voluntarily provide blood, which is then collected, tested, and administered to patients in need of additional blood components due to medical conditions, surgeries, accidents, or illnesses. Hepatitis diagnostic tests are essential for thoroughly screening blood before donation or transfusion, ensuring patient safety. For instance, in August 2023, the Royal College of Pathologists, a UK-based organization, reported that blood transfusion is the most commonly performed procedure for hospitalized patients, with nearly 2 million blood components issued and transfused annually in England, costing over £300 million ($390.69 million). Thus, the growing number of blood transfusions and donations supports the expansion of the hepatitis diagnostic test market.
The surge in hepatitis cases globally is another key factor propelling the growth of the hepatitis diagnostic tests market. Hepatitis, characterized by liver inflammation, poses significant health risks and can lead to various symptoms and complications. Accurate diagnostic tests for hepatitis are crucial in identifying and confirming the presence of hepatitis infections, enabling timely interventions and effective disease management. For instance, according to the Hepatitis B Foundation in 2023, an estimated 1.5 million people contract hepatitis infections annually, highlighting the persistent challenge posed by these diseases. The growing incidence of hepatitis underlines the critical importance of reliable diagnostic tests in early detection and management, thereby fueling the demand for hepatitis diagnostic tests in the market.
Dominant players in the hepatitis diagnostic test market are concentrating on innovating automated immunoassays, exemplified by the Elecsys HCV Duo, to enhance customer service reliability. Automated immunoassays represent laboratory techniques utilizing automated systems and specialized instruments to conduct various phases of the immunoassay process, encompassing sample handling, reagent mixing, incubation, detection, and result calculation. For instance, in July 2023, Roche Diagnostics India, a biotechnology research company based in India, introduced Elecsys HCV Duo. This advanced solution represents India's maiden fully automated immunoassay available commercially, facilitating the simultaneous and independent evaluation of hepatitis C virus (HCV) antigen and antibody levels from a single human plasma or serum sample. Moreover, this approach streamlines the diagnostic procedure, enabling single-specimen testing and potentially reducing the number of necessary follow-up visits, consequently alleviating the burden on healthcare systems.
In October 2024, The Bank of Nova Scotia, a Canada-based company, acquired Bio-Rad Laboratories Inc. for an undisclosed amount. This acquisition allows The Bank of Nova Scotia to diversify its portfolio by integrating Bio-Rad Laboratories' expertise in hepatitis diagnostic testing. Bio-Rad Laboratories Inc., a U.S.-based company, is known for its products and services in diagnostic testing for hepatitis.
North America was the largest region in the hepatitis diagnostic tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis diagnostic tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the hepatitis diagnostic tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hepatitis diagnostic test market consists of revenues earned by entities by providing diagnostic services such as liver ultrasound, computerized tomography (CT) scans, and antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepatitis diagnostic test market also includes sales of laboratory equipment, reagents, and assay components that are used in providing hepatitis diagnostic test services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hepatitis Diagnostic Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hepatitis diagnostic tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hepatitis diagnostic tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hepatitis diagnostic tests market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Blood Tests; Imaging Tests; Liver Biopsy
2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Diagnostic Tests (RDTs); Polymerase Chain Reaction (PCR); Isothermal Nucleic Acid Amplification Test (INAAT); Other Technologies
3) By End User: Hospitals; Diagnostic Laboratories; Blood Bank; Other End Users
3. Hepatitis Diagnostic Tests Market Trends And Strategies
4. Hepatitis Diagnostic Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Hepatitis Diagnostic Tests Growth Analysis And Strategic Analysis Framework
5.1. Global Hepatitis Diagnostic Tests PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Hepatitis Diagnostic Tests Market Growth Rate Analysis
5.4. Global Hepatitis Diagnostic Tests Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Hepatitis Diagnostic Tests Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Hepatitis Diagnostic Tests Total Addressable Market (TAM)
6. Hepatitis Diagnostic Tests Market Segmentation
6.1. Global Hepatitis Diagnostic Tests Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Tests
Imaging Tests
Liver Biopsy
6.2. Global Hepatitis Diagnostic Tests Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDTs)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Test (INAAT)
Other Technologies
6.3. Global Hepatitis Diagnostic Tests Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Laboratories
Blood Bank
Other End Users
6.4. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Blood Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Serological Tests
Polymerase Chain Reaction (PCR) Tests
Enzyme-Linked Immunosorbent Assays (ELISA)
6.5. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Imaging Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ultrasound
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
6.6. Global Hepatitis Diagnostic Tests Market, Sub-Segmentation Of Liver Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Percutaneous Biopsy
Transjugular Biopsy
Laparoscopic Biopsy
7. Hepatitis Diagnostic Tests Market Regional And Country Analysis
7.1. Global Hepatitis Diagnostic Tests Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Hepatitis Diagnostic Tests Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
